Effective Therapy, Reliable Delivery —

with 2 convenient delivery systems!



Low-dose inhaled corticosteroids (ICSs) like FLOVENT are the preferred initial daily therapy for children 5 to 11 years old with persistent asthma, according to the National Institutes of Health.1

Important Information About FLOVENT HFA and FLOVENT DISKUS
Prescription FLOVENT HFA and FLOVENT DISKUS are for patients with asthma 4 years of age and older. FLOVENT does not replace fast-acting (rescue) inhalers for sudden symptoms. Inhaled corticosteroids, as well as poorly controlled asthma, may cause a reduction in growth rate. The long-term effect on final adult height is unknown. People switching from an oral steroid, like prednisone, to FLOVENT need to be especially careful. While adjusting to the switch, your body is not as able to heal after surgery, infection, or serious injury. See your doctor if your asthma does not improve. The use of FLOVENT HFA in children 4 to 11 years old is based in part on results of studies in patients 12 years and older and other FLOVENT products.

Reference: 1. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3 2007). NIH Item No. 07-4051. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed November 16, 2007.



You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

GSK Corporation    GSK For You    Contact Us

This site is intended for US residents only.
© 1997-2009 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us